SECCHI, MASSIMILIANO
SECCHI, MASSIMILIANO
Combination of the CCL5-derived peptide R4.0 with different HIV-1 blockers reveals wide target compatibility and synergic cobinding to CCR5
2014-01-01 Secchi, M.; Vassena, L.; Morin, S.; Schols, D.; Vangelista, L.
Editorial: CCR5: A receptor at the center stage in infection
2022-01-01 Ellwanger, Joel Henrique; Secchi, Massimiliano; Aliberti, Julio; Vangelista, Luca
Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers
2010-01-01 Vangelista, L.; Secchi, M.; Liu, X.; Bachi, A.; Jia, L.; Xu, Q.; Lusso, P.
Enhancement of anti-HIV-1 activity by hot spot evolution of RANTES-derived peptides
2012-01-01 Secchi, M.; Longhi, R.; Vassena, L.; Sironi, F.; Grzesiek, S.; Lusso, P.; Vangelista, L.
Modified microbiota for microbicide drug delivery
2014-01-01 Vangelista, Luca; Secchi, Massimiliano
Molecular engineering of RANTES peptide mimetics with potent anti-HIV-1 activity
2011-01-01 Lusso, P.; Vangelista, L.; Cimbro, R.; Secchi, M.; Sironi, F.; Longhi, R.; Faiella, M.; Maglio, O.; Pavone, V.
Prepare for the Future: Dissecting the Spike to Seek Broadly Neutralizing Antibodies and Universal Vaccine for Pandemic Coronaviruses
2020-01-01 Vangelista, L.; Secchi, M.
Rational CCL5 mutagenesis integration in a lactobacilli platform generates extremely potent HIV-1 blockers
2018-01-01 Secchi, M.; Grampa, V.; Vangelista, L.
Rational design of novel HIV-1 entry inhibitors by RANTES engineering
2008-01-01 Vangelista, L.; Secchi, M.; Lusso, P.
Rational Engineering of a Sub-Picomolar HIV-1 Blocker
2022-01-01 Secchi, M.; Vangelista, L.
The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutants
2009-01-01 Secchi, M.; Xu, Q.; Lusso, P.; Vangelista, L.